9 completed, 6 unknown, 4 terminated, 2 enrolling by invitation. 10 Phase 2, 5 Not applicable, 4 Phase 1, 2 Early Phase 1.
Follow Squamous Cell Carcinoma of the Skin: new trials by email Literature Review of Squamous Cell Carcinoma of the Skin trials Research Report on Squamous Cell Carcinoma of the Skin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark. Follow-up visit at least two years after treatment - Non-Melanoma Skin Cancer (NMSC), Basal Cell Carcinoma of Skin | Enrolling by invitation | University of Aarhus | 2900 | 2025-12-15 | 2026-01-16 | |
| Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma Microdevice - Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma | Early Phase 1 | Enrolling by invitation | Oliver Jonas | 25 | 2025-10-01 | 2026-05-18 |
| CivaDerm(TM) Surface Therapy Pilot Study CivaDerm - Basal Cell Carcinoma, Squamous Cell Carcinoma of the Skin | Early Phase 1 | Completed | CivaTech Oncology | 10 | 2024-05-01 | 2026-03-24 |
| Intratumoral PH-762 for Cutaneous Carcinoma PH-762 - Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin | Phase 1 | Completed | Phio Pharmaceuticals Inc. | 22 | 2023-11-07 | 2026-09-21 |
| Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology Squamous Cell Carcinoma of the Skin | Active not recruiting | Queen Mary University of London | 300 | 2023-10-20 | 2026-04-02 | |
| Carrilizumab Combined With White Purple for Squamous Cell Carcinoma of Skin Carrilizumab with albumin-binding paclitaxel - Squamous Cell Carcinoma of the Skin | Not applicable | Unknown | Henan Cancer Hospital | 24 | 2023-06-08 | 2023-08-08 |
| Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma Camrelizumab - Squamous Cell Carcinoma of the Skin | Phase 2 | Unknown | Henan Cancer Hospital | 20 | 2022-08-05 | 2023-11-08 |
| Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy Peripheral blood sampling in order to evaluate changes in the circulating immune population - Squamous Cell Carcinoma of the Skin | Unknown | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 42 | 2022-03-01 | 2022-02-18 | |
| Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region Regular care with additionally administration of questionnaires - Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck | Completed | Maastricht University Medical Center | 78 | 2022-02-28 | 2026-01-06 | |
| Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy Conventional Therapy acc. to prevailing clincal approved schemes - HNSCC, NSCLC | Recruiting | University of Erlangen-Nürnberg Medical School | 200 | 2021-04-30 | 2025-09-17 | |
| The UNSCARRed Study: UNresctable Squamous Cell Carcinoma Treated With Avelumab and Radical Radiotherapy Avelumab and Radical radiotherapy - Squamous Cell Carcinoma of the Skin | Phase 2 | Terminated | AHS Cancer Control Alberta | 8 | 2019-04-12 | 2025-06-27 |
| SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas SL-279252 - Squamous Cell Carcinoma of the Head and Neck, Melanoma | Phase 1 | Completed | Shattuck Labs, Inc. | 49 | 2019-03-26 | 2025-04-02 |
| Elucid Labs AIDA™ - Labelled Image Acquisition Protocol Artificial Intelligence Dermatology Assistant (AIDA™) - Melanoma (Skin), Basal Cell Carcinoma of the Skin | Not applicable | Unknown | Elucid Labs Inc. | 4000 | 2018-10-15 | 2018-08-08 |
| How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes Immunotherapy - Autoimmunity, Melanoma | Terminated | Washington University School of Medicine | 54 | 2017-11-08 | 2024-09-05 | |
| Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC CV8102, CV8102 + anti-PD-1 therapy - Melanoma (Skin), Squamous Cell Carcinoma of the Skin | Phase 1 | Unknown | CureVac | 98 | 2017-09-25 | 2021-11-04 |
| Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin Nivolumab, Nivolumab plus Relatlimab - Squamous Cell Carcinoma of the Skin | Phase 2 | Recruiting | Salzburger Landeskliniken | 61 | 2017-03-06 | 2024-04-18 |
| Investigation of Desmoplastic Squamous Cell Carcinoma Immunohistochemistry using Pancytokeratin Staining - Squamous Cell Carcinoma of the Skin | Not applicable | Unknown | University Hospital Tuebingen | 73 | 2016-01-01 | 2016-03-25 |
| Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer cetuximab, laboratory biomarker analysis - Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin | Not applicable | Completed | Rutgers, The State University of New Jersey | 15 | 2015-01-30 | 2023-12-20 |
| Preventing Squamous Cell Skin Cancer Pioglitazone - Squamous Cell Carcinoma of the Skin | Phase 2 | Completed | University of Rochester | 12 | 2014-11-01 | 2020-06-23 |
| Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC) Poly-ICLC - Melanoma, Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Terminated | Nina Bhardwaj | 8 | 2013-11-01 | 2018-01-23 |
Showing 20 of 26. Sign in to see all of them.
Skin Neoplasms (11) · Melanoma (7) · Carcinoma, Basal Cell (6) · Squamous Cell Carcinoma of Head and Neck (5) · Carcinoma, Squamous Cell (4) · Carcinoma, Renal Cell (2) · Carcinoma, Transitional Cell (2) · Anus Neoplasms (1) · Autoimmune Diseases (1) · Breast Neoplasms (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Carotid Intimal Medial Thickness 1 (1) · Esophageal Neoplasms (1)
Neoplasms (20) · Neoplasms by Site (17) · Neoplasms by Histologic Type (16) · Skin Diseases (16) · Skin and Connective Tissue Diseases (16) · Carcinoma (14) · Neoplasms, Glandular and Epithelial (14) · Neoplasms, Germ Cell and Embryonal (7) · Neoplasms, Nerve Tissue (7) · Neuroectodermal Tumors (7) · Neuroendocrine Tumors (7) · Nevi and Melanomas (7) · Neoplasms, Basal Cell (6) · Head and Neck Neoplasms (5) · Skin Neoplasms (5)
Radiation (2) · Radiotherapy (2) · 3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol (1) · Aftercare (1) · Capecitabine (1) · Cetuximab (1) · Cisplatin (1) · Congresses as Topic (1) · Dasatinib (1) · Deoxyribonuclease (Pyrimidine Dimer) (1) · Erlotinib Hydrochloride (1) · Gefitinib (1) · Immunotherapy (1) · Melphalan (1) · Nivolumab (1)
National Cancer Institute (NCI) (3) · Henan Cancer Hospital (2) · AHS Cancer Control Alberta (1) · Albert Einstein College of Medicine (1) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1) · CivaTech Oncology (1) · CureVac (1) · Elucid Labs Inc. (1) · Maastricht University Medical Center (1) · Nina Bhardwaj (1) · OHSU Knight Cancer Institute (1) · Oliver Jonas (1) · Phio Pharmaceuticals Inc. (1) · Queen Mary University of London (1) · Rutgers, The State University of New Jersey (1)
United States (13) · Canada (3) · Germany (3) · Austria (2) · China (2) · Spain (2) · Belgium (1) · Denmark (1) · France (1) · Netherlands (1) · Russia (1) · United Kingdom (1)
Adam Berger, MD (1) · Alexander Colevas (1) · Alice P. Pentland, M.D. (1) · Anita Gothelf, MD PhD (1) · Benjamin Frey, PD Dr. Dr. (1) · Craig Elmets (1) · Gulalai Hanan, MD (1) · Jesper Grau Eriksen, Professor MD PhD (1) · John Arlette, MD (1) · John Walker, Walker (1) · K Mosterd, MD, PhD (1) · Katia Papalezova (1) · Linda Mahoney (1) · Markus Hecht, PD Dr. (1) · Martin Laimer, MD (1)
PMID 23648440, PMID 24801836, PMID 25189484, PMID 29332704, PMID 29537906, PMID 29863979, PMID 30227198, PMID 30540123, PMID 30570645, PMID 31022866, PMID 31261963, PMID 32113941, PMID 32113942, PMID 32289475, PMID 32344066, PMID 32351136, PMID 32372702, PMID 36319717, PMID 39697325, PMID 39904560, PMID 40042547, PMID 40442261
N01CM00070 (1), P30CA013330 (1), P30CA016058 (1), P30CA072720 (1)